Current Report · Items 5.02, 9.01 · 8-K

InspireMD Inc.

NSPRNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Filed Jul 2, 2026Accepted Jul 2, 2026, 5:00 PM EDTCIK 1433607Accession 0001493152-26-031945

Company context

InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Current securities

NSPRNASDAQ · EQUITY · Current

Historical securities (4)

NSPRWNASDAQ · WARRANT · Historical · closed Jul 7, 2021 NSPR.WSAMEX · WARRANT · Historical · closed Jun 7, 2021 NSPR.WS.BNYSE_AMERICAN · WARRANT · Historical · closed Jun 7, 2021 NSPRZNASDAQ · WARRANT · Historical · closed Mar 15, 2022

Recent company filings

Registered securities in this filing

InspireMD, Inc. · 8-K · Filed 2026-07-02

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.0001 par value per share

Symbol: NSPR
Exchange: NASDAQ
Classification: COMMON
Status: Current

Filing context

Context: AsOf2026-06-26

Dimensions: Not supplied

Accession 000149315226031945 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors

Item 5.02. Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 26, 2026, Mr. Raymond W. Cohen, a Class III member of the board of directors (the “Board”) of InspireMD, Inc. (the “Company”), a member of the Audit Committee of the Board and a member of the Compensation Committee of the Board, tendered his resignation from the Board, effective July 1, 2026. Mr. Cohen’s resignation from the Board was for personal considerations and not due to any disagreement with the Company, the Board or the management of the Company on any matter relating to the Company’s operations, policies, practices or otherwise. The Nominating and Corporate Governance Committee of the Board intends to identify and evaluate suitable candidates to fill the vacancy created by Mr. Cohen’s resignation.

Get the free weekly BCS email.